Clinically, METTL16 expression was positively correlated with SOGA1 and PDK4 expression in CRC tissues, suggesting the clinical significance of the METTL16/SOGA1/PDK4 axis in promoting CRC progression. Here, METTL16 is linked to colorectal carcinoma.